Ativo Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Ativo Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-33,096	Closed	-$1.43M	–	257
2017 Q4	$1.43M	Buy	33,096 +10,504	+46%	+$472K	0.38%	86
2017 Q3	$1.05M	Buy	22,592 +3,000	+15%	+$144K	0.28%	163
2017 Q2	$970K	Hold	19,592	–	–	0.26%	170
2017 Q1	$1.07M	Hold	19,592	–	–	0.27%	151
2016 Q4	$1.09M	Hold	19,592	–	–	0.26%	149
2016 Q3	$895K	Hold	19,592	–	–	0.21%	171
2016 Q2	$782K	Buy	19,592 +8,200	+72%	+$300K	0.19%	178
2016 Q1	$397K	Hold	11,392	–	–	0.11%	179
2015 Q4	$489K	Buy	11,392 +700	+7%	+$35.1K	0.12%	160
2015 Q3	$593K	Buy	10,692 +100	+0.9%	+$5.4K	0.16%	124
2015 Q2	$613K	Sell	10,592 -2,483	-19%	-$106K	0.22%	92
2015 Q1	$512K	Sell	13,075 -1	-0%	-$39	0.2%	122
2014 Q4	$505K	Sell	13,076 -1,402	-10%	-$53.5K	0.21%	130
2014 Q3	$511K	Buy	14,478 +3	+0%	+$88	0.2%	90
2014 Q2	$390K	Hold	14,475	–	–	0.17%	147
2014 Q1	$375K	Buy	+14,475	New	+$347K	0.15%	157

Other funds holding BSTC

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ativo Capital Management's BSTC Position: Q1 2018 in Review

Ativo Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 33,096 shares — an estimated $1.43M sold.

Ativo Capital Management first reported a position in BSTC in Q1 2014 and held it in 16 quarters. The position peaked at $1.43M in Q4 2017. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

Ativo Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
Ativo Capital Management sold 33,096 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $1.43M.
Ativo Capital Management first reported a position in BioSpecifics Technologies Corp. in Q1 2014 and held it in 16 quarters.
Ativo Capital Management's BioSpecifics Technologies Corp. position peaked at $1.43M in Q4 2017.
78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on Ativo Capital Management's 13F filing for Q1 2018, filed 15 May 2018.